Literature DB >> 8995692

Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1.

M N Saarloos1, B L Sullivan, M A Czerniewski, K D Parameswar, G T Spear.   

Abstract

This study determined whether HLA-DR was incorporated into human immunodeficiency virus type 1 produced in vivo or by primary cultured cells. HLA-DR was associated with virions from primary isolates, macrophage cultures, and blood plasma. These results represent the first demonstration of major histocompatibility complex molecules associated with an in vivo source of virus.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 8995692      PMCID： PMC191223     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  20 in total

1.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

2.  HLA class II on HIV particles is functional in superantigen presentation to human T cells: implications for HIV pathogenesis.

Authors:  J L Rossio; J Bess; L E Henderson; P Cresswell; L O Arthur
Journal:  AIDS Res Hum Retroviruses       Date:  1995-12       Impact factor: 2.205

3.  Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.

Authors:  B L Sullivan; E J Knopoff; M Saifuddin; D M Takefman; M N Saarloos; B E Sha; G T Spear
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

4.  Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study.

Authors:  T Meerloo; M A Sheikh; A C Bloem; A de Ronde; M Schutten; C A van Els; P J Roholl; P Joling; J Goudsmit; H J Schuurman
Journal:  J Gen Virol       Date:  1993-01       Impact factor: 3.891

5.  Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.

Authors:  L O Arthur; J W Bess; R C Sowder; R E Benveniste; D L Mann; J C Chermann; L E Henderson
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

6.  Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV.

Authors:  R J Orentas; J E Hildreth
Journal:  AIDS Res Hum Retroviruses       Date:  1993-11       Impact factor: 2.205

7.  A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles.

Authors:  M R Capobianchi; S Fais; C Castilletti; M Gentile; F Ameglio; F Dianzani
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

8.  The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific.

Authors:  R Cantin; J F Fortin; M Tremblay
Journal:  Virology       Date:  1996-04-15       Impact factor: 3.616

9.  Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis.

Authors:  M Saifuddin; M Ghassemi; C Patki; C J Parker; G T Spear
Journal:  AIDS Res Hum Retroviruses       Date:  1994-07       Impact factor: 2.205

10.  Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes.

Authors:  M P Bevilacqua; D Amrani; M W Mosesson; C Bianco
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307
View more
  15 in total

1.  Expression of MHC class II in T cells is associated with increased HIV-1 expression.

Authors:  M Saifuddin; G T Spear; C Chang; K A Roebuck
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection.

Authors:  S D Lawn; S T Butera
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection.

Authors:  S D Lawn; B D Roberts; G E Griffin; T M Folks; S T Butera
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation.

Authors:  Daniel M Takefman; Gregory T Spear; Mohammed Saifuddin; Carolyn A Wilson
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation.

Authors:  M T Esser; D R Graham; L V Coren; C M Trubey; J W Bess; L O Arthur; D E Ott; J D Lifson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization.

Authors:  A N Vzorov; R W Compans
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins.

Authors:  H M Naif; S Li; M Alali; J Chang; C Mayne; J Sullivan; A L Cunningham
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Efficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packaging.

Authors:  D T Poon; L V Coren; D E Ott
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity.

Authors:  J S Paquette; J F Fortin; L Blanchard; M J Tremblay
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Membrane transplantation to correct integral membrane protein defects.

Authors:  Kimberly V Curlee; Jeong S Hong; J P Clancy; Scott A King; Eric Hunter; Bakhrom Berdiev; Dale Benos; Maja A Sommerfelt; Eric J Sorscher; Michael Sakalian
Journal:  J Mol Med (Berl)       Date:  2003-07-23       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.